We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.17B
AUM Growth
+$77.9M
Cap. Flow
-$44.2M
Cap. Flow %
-1.06%
Top 10 Hldgs %
7.1%
Holding
2,159
New
572
Increased
455
Reduced
482
Closed
650

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$40.7M
2
AAPL icon
Apple
AAPL
+$38.3M
3
SPGI icon
S&P Global
SPGI
+$36.6M
4
FDS icon
Factset
FDS
+$29.2M
5
FISV
Fiserv Inc
FISV
+$25.2M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31.1M
2
RKLB icon
Rocket Lab Corp
RKLB
+$27.8M
3
INSM icon
Insmed
INSM
+$26.8M
4
TMUS icon
T-Mobile US
TMUS
+$24.5M
5
WBD icon
Warner Bros
WBD
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 22.04%
2 Industrials 13.87%
3 Financials 12.48%
4 Consumer Discretionary 11.72%
5 Healthcare 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGCO icon
1526
AGCO
AGCO
$8.96B
– –
-13,616
Closed -$1.4M
AGI icon
1527
Alamos Gold
AGI
$12.1B
– –
-56,567
Closed -$1.5M
AIZ icon
1528
Assurant
AIZ
$14B
– –
-14,280
Closed -$2.82M
AJG icon
1529
Arthur J. Gallagher & Co
AJG
$68.2B
– –
-13,265
Closed -$4.25M
AKBA icon
1530
Akebia Therapeutics
AKBA
$341M
– –
-30,657
Closed -$112K
AKR icon
1531
Acadia Realty Trust
AKR
$2.96B
– –
-138,956
Closed -$2.58M
AKYA
1532
DELISTED
Akoya BioSciences
AKYA
– –
-26,464
Closed -$34.4K
ALB icon
1533
Albemarle
ALB
$13.3B
– –
-66,401
Closed -$4.16M
ALGT icon
1534
Allegiant Air
ALGT
$2.73B
– –
-35,577
Closed -$1.95M
ALL icon
1535
Allstate
ALL
$70.1B
– –
-68,107
Closed -$13.7M
ALLE icon
1536
Allegion
ALLE
$13.7B
– –
-25,997
Closed -$3.75M
AMAT icon
1537
Applied Materials
AMAT
$378B
– –
-24,989
Closed -$4.57M
AME icon
1538
Ametek
AME
$55.3B
– –
-25,734
Closed -$4.66M
AMED
1539
DELISTED
Amedisys
AMED
– –
-8,475
Closed -$834K
AMG icon
1540
Affiliated Managers Group
AMG
$9.78B
– –
-4,657
Closed -$916K
AMLP icon
1541
Alerian MLP ETF
AMLP
$12.9B
– –
-10,353
Closed -$506K
AMLX icon
1542
Amylyx Pharmaceuticals
AMLX
$2.17B
– –
-240,379
Closed -$1.54M
AMPY icon
1543
Amplify Energy
AMPY
$152M
– –
-41,386
Closed -$132K
GOLD
1544
Gold.com Inc
GOLD
$1.18B
– –
-31,855
Closed -$707K
AMR icon
1545
Alpha Metallurgical Resources
AMR
$1.84B
– –
-6,076
Closed -$683K
AMRC icon
1546
Ameresco
AMRC
$1.04B
– –
-37,866
Closed -$575K
AMTX icon
1547
Aemetis
AMTX
$104M
– –
-20,556
Closed -$51K
APG icon
1548
APi Group
APG
$17B
– –
-61,743
Closed -$2.1M
APO icon
1549
Apollo Global Management
APO
$71.9B
– –
-37,600
Closed -$5.33M
APP icon
1550
Applovin
APP
$140B
– –
-43,114
Closed -$15.1M
60 61
62
63 64

Similar funds

HSA
HBK Sorce Advisory Erie, Pennsylvania $5.05B AUM 16.64% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
LFG
Lazard Frères Gestion Paris, France $5.07B AUM 20.66% 1-Year Est. Return
JIM
Jensen Investment Management Lake Oswego, Oregon $5.07B AUM 4.98% 1-Year Est. Return
CTC
Central Trust Company Jefferson City, Missouri $5.08B AUM 25.65% 1-Year Est. Return
NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
BPWM
Badgley Phelps Wealth Managers Seattle, Washington $5.02B AUM 21.87% 1-Year Est. Return

Y-Intercept (HK)'s Q3 2025 Portfolio in Review

As of Q3 2025, Y-Intercept (HK) held 2,159 positions worth $4.17B, up 1.9% from $4.09B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Y-Intercept (HK)'s Q3 2025 filing shows 572 new, 455 increased, 482 reduced and 650 closed positions. Its largest new stake was NVIDIA: 233,683 shares worth $43.6M. The largest sale was UnitedHealth, an estimated $31.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

  • Y-Intercept (HK)'s largest Q3 2025 buy was NVIDIA: 233,683 shares worth $43.6M.
  • Y-Intercept (HK) added most to S&P Global in Q3 2025, an estimated $36.6M increase.
  • Y-Intercept (HK)'s biggest Q3 2025 reduction was Insmed, cutting an estimated $26.8M.
  • Y-Intercept (HK) fully exited UnitedHealth in Q3 2025, selling an estimated $31.1M.
  • Y-Intercept (HK)'s ten largest holdings make up 7.1% of its $4.17B portfolio in Q3 2025.
  • Y-Intercept (HK) opened 572 new positions and closed 650 in Q3 2025.
  • Y-Intercept (HK)'s portfolio value rose 1.9% quarter-over-quarter to $4.17B.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.